nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—CYP3A4—bone cancer	0.932	1	CbGaD
Alfentanil—ALB—Methotrexate—bone cancer	0.00734	0.313	CbGbCtD
Alfentanil—ABCB1—Cisplatin—bone cancer	0.00591	0.253	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—bone cancer	0.00396	0.169	CbGbCtD
Alfentanil—ABCB1—Methotrexate—bone cancer	0.00384	0.164	CbGbCtD
Alfentanil—Sufentanil—CYP3A4—bone cancer	0.00312	0.746	CrCbGaD
Alfentanil—CYP3A4—Doxorubicin—bone cancer	0.00237	0.101	CbGbCtD
Alfentanil—Fentanyl—CYP3A4—bone cancer	0.00106	0.254	CrCbGaD
Alfentanil—Pain—Carboplatin—bone cancer	0.000944	0.0235	CcSEcCtD
Alfentanil—Hiccups—Cisplatin—bone cancer	0.000907	0.0226	CcSEcCtD
Alfentanil—Body temperature increased—Carboplatin—bone cancer	0.000872	0.0217	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Cisplatin—bone cancer	0.00068	0.0169	CcSEcCtD
Alfentanil—Dermatitis atopic—Epirubicin—bone cancer	0.000629	0.0157	CcSEcCtD
Alfentanil—Apnoea—Methotrexate—bone cancer	0.000587	0.0146	CcSEcCtD
Alfentanil—Dermatitis atopic—Doxorubicin—bone cancer	0.000582	0.0145	CcSEcCtD
Alfentanil—Injection site pain—Epirubicin—bone cancer	0.000571	0.0142	CcSEcCtD
Alfentanil—Injection site pain—Doxorubicin—bone cancer	0.000528	0.0131	CcSEcCtD
Alfentanil—Dyskinesia—Epirubicin—bone cancer	0.000496	0.0123	CcSEcCtD
Alfentanil—Hiccups—Epirubicin—bone cancer	0.000466	0.0116	CcSEcCtD
Alfentanil—Bradycardia—Cisplatin—bone cancer	0.000464	0.0115	CcSEcCtD
Alfentanil—Dyskinesia—Doxorubicin—bone cancer	0.000459	0.0114	CcSEcCtD
Alfentanil—Connective tissue disorder—Cisplatin—bone cancer	0.000448	0.0111	CcSEcCtD
Alfentanil—Visual impairment—Cisplatin—bone cancer	0.000439	0.0109	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—bone cancer	0.000431	0.0107	CcSEcCtD
Alfentanil—Eye disorder—Cisplatin—bone cancer	0.000426	0.0106	CcSEcCtD
Alfentanil—Cardiac disorder—Cisplatin—bone cancer	0.000423	0.0105	CcSEcCtD
Alfentanil—Immune system disorder—Cisplatin—bone cancer	0.000411	0.0102	CcSEcCtD
Alfentanil—Mediastinal disorder—Cisplatin—bone cancer	0.000411	0.0102	CcSEcCtD
Alfentanil—Arrhythmia—Cisplatin—bone cancer	0.000407	0.0101	CcSEcCtD
Alfentanil—Erythema—Cisplatin—bone cancer	0.000397	0.00987	CcSEcCtD
Alfentanil—Visual disturbance—Methotrexate—bone cancer	0.000381	0.00949	CcSEcCtD
Alfentanil—Vision blurred—Cisplatin—bone cancer	0.000374	0.0093	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Methotrexate—bone cancer	0.000373	0.00929	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—bone cancer	0.000349	0.0087	CcSEcCtD
Alfentanil—Convulsion—Cisplatin—bone cancer	0.000344	0.00855	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000335	0.00835	CcSEcCtD
Alfentanil—Anaphylactic shock—Cisplatin—bone cancer	0.000324	0.00806	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000323	0.00805	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—bone cancer	0.000322	0.008	CcSEcCtD
Alfentanil—Nervous system disorder—Cisplatin—bone cancer	0.000317	0.0079	CcSEcCtD
Alfentanil—Tachycardia—Cisplatin—bone cancer	0.000316	0.00786	CcSEcCtD
Alfentanil—Skin disorder—Cisplatin—bone cancer	0.000314	0.00783	CcSEcCtD
Alfentanil—Hyperhidrosis—Cisplatin—bone cancer	0.000313	0.00779	CcSEcCtD
Alfentanil—Hypotension—Cisplatin—bone cancer	0.000302	0.00753	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—bone cancer	0.000298	0.00741	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Cisplatin—bone cancer	0.000279	0.00696	CcSEcCtD
Alfentanil—Drowsiness—Methotrexate—bone cancer	0.000278	0.00693	CcSEcCtD
Alfentanil—Pain—Cisplatin—bone cancer	0.000277	0.00689	CcSEcCtD
Alfentanil—Feeling abnormal—Cisplatin—bone cancer	0.000267	0.00664	CcSEcCtD
Alfentanil—Epistaxis—Methotrexate—bone cancer	0.000263	0.00654	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—bone cancer	0.000261	0.00649	CcSEcCtD
Alfentanil—Body temperature increased—Cisplatin—bone cancer	0.000256	0.00637	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—bone cancer	0.000246	0.00612	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—bone cancer	0.000241	0.006	CcSEcCtD
Alfentanil—Visual impairment—Methotrexate—bone cancer	0.000241	0.006	CcSEcCtD
Alfentanil—Hypersensitivity—Cisplatin—bone cancer	0.000238	0.00594	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—bone cancer	0.000238	0.00593	CcSEcCtD
Alfentanil—Eye disorder—Methotrexate—bone cancer	0.000234	0.00582	CcSEcCtD
Alfentanil—Asthenia—Cisplatin—bone cancer	0.000232	0.00578	CcSEcCtD
Alfentanil—Cardiac disorder—Methotrexate—bone cancer	0.000232	0.00578	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—bone cancer	0.00023	0.00572	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—bone cancer	0.000227	0.00566	CcSEcCtD
Alfentanil—Angiopathy—Methotrexate—bone cancer	0.000227	0.00565	CcSEcCtD
Alfentanil—Immune system disorder—Methotrexate—bone cancer	0.000226	0.00562	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—bone cancer	0.000225	0.00561	CcSEcCtD
Alfentanil—Mediastinal disorder—Methotrexate—bone cancer	0.000225	0.00561	CcSEcCtD
Alfentanil—Chills—Methotrexate—bone cancer	0.000224	0.00558	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—bone cancer	0.00022	0.00549	CcSEcCtD
Alfentanil—Mental disorder—Methotrexate—bone cancer	0.000219	0.00545	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—bone cancer	0.000219	0.00544	CcSEcCtD
Alfentanil—Erythema—Methotrexate—bone cancer	0.000218	0.00542	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—bone cancer	0.000217	0.0054	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—bone cancer	0.000213	0.0053	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—bone cancer	0.000212	0.00528	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—bone cancer	0.000211	0.00526	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—bone cancer	0.000211	0.00525	CcSEcCtD
Alfentanil—Chills—Epirubicin—bone cancer	0.00021	0.00523	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—bone cancer	0.000209	0.0052	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—bone cancer	0.000209	0.00519	CcSEcCtD
Alfentanil—Vomiting—Cisplatin—bone cancer	0.000206	0.00512	CcSEcCtD
Alfentanil—Vision blurred—Methotrexate—bone cancer	0.000205	0.00511	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—bone cancer	0.000205	0.0051	CcSEcCtD
Alfentanil—Rash—Cisplatin—bone cancer	0.000204	0.00508	CcSEcCtD
Alfentanil—Dermatitis—Cisplatin—bone cancer	0.000204	0.00508	CcSEcCtD
Alfentanil—Erythema—Epirubicin—bone cancer	0.000204	0.00507	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—bone cancer	0.000202	0.00504	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—bone cancer	0.000201	0.005	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—bone cancer	0.000196	0.00489	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—bone cancer	0.000196	0.00487	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—bone cancer	0.000195	0.00486	CcSEcCtD
Alfentanil—Chills—Doxorubicin—bone cancer	0.000194	0.00483	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—bone cancer	0.000193	0.00481	CcSEcCtD
Alfentanil—Nausea—Cisplatin—bone cancer	0.000192	0.00479	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—bone cancer	0.000192	0.00478	CcSEcCtD
Alfentanil—Cough—Methotrexate—bone cancer	0.00019	0.00473	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—bone cancer	0.00019	0.00472	CcSEcCtD
Alfentanil—Convulsion—Methotrexate—bone cancer	0.000189	0.00469	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—bone cancer	0.000188	0.00469	CcSEcCtD
Alfentanil—Agitation—Epirubicin—bone cancer	0.000187	0.00466	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000184	0.00458	CcSEcCtD
Alfentanil—Confusional state—Methotrexate—bone cancer	0.000179	0.00446	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—bone cancer	0.000179	0.00446	CcSEcCtD
Alfentanil—Cough—Epirubicin—bone cancer	0.000178	0.00442	CcSEcCtD
Alfentanil—Anaphylactic shock—Methotrexate—bone cancer	0.000178	0.00442	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—bone cancer	0.000178	0.00442	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—bone cancer	0.000176	0.00439	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—bone cancer	0.000176	0.00438	CcSEcCtD
Alfentanil—Nervous system disorder—Methotrexate—bone cancer	0.000174	0.00434	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—bone cancer	0.000173	0.00431	CcSEcCtD
Alfentanil—Skin disorder—Methotrexate—bone cancer	0.000173	0.00429	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000172	0.00429	CcSEcCtD
Alfentanil—Hyperhidrosis—Methotrexate—bone cancer	0.000172	0.00427	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—bone cancer	0.000168	0.00417	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—bone cancer	0.000166	0.00414	CcSEcCtD
Alfentanil—Hypotension—Methotrexate—bone cancer	0.000166	0.00413	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—bone cancer	0.000166	0.00412	CcSEcCtD
Alfentanil—Cough—Doxorubicin—bone cancer	0.000164	0.00409	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—bone cancer	0.000163	0.00406	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—bone cancer	0.000163	0.00406	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—bone cancer	0.000163	0.00405	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—bone cancer	0.000162	0.00404	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—bone cancer	0.000161	0.00402	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—bone cancer	0.000161	0.004	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000159	0.00397	CcSEcCtD
Alfentanil—Somnolence—Methotrexate—bone cancer	0.000158	0.00393	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—bone cancer	0.000155	0.00387	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—bone cancer	0.000155	0.00386	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—bone cancer	0.000154	0.00383	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Methotrexate—bone cancer	0.000153	0.00382	CcSEcCtD
Alfentanil—Fatigue—Methotrexate—bone cancer	0.000153	0.00381	CcSEcCtD
Alfentanil—Pain—Methotrexate—bone cancer	0.000152	0.00378	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—bone cancer	0.000151	0.00375	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—bone cancer	0.00015	0.00374	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—bone cancer	0.000149	0.00372	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—bone cancer	0.000149	0.0037	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—bone cancer	0.000148	0.00368	CcSEcCtD
Alfentanil—Feeling abnormal—Methotrexate—bone cancer	0.000146	0.00364	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—bone cancer	0.000144	0.00358	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—bone cancer	0.000143	0.00357	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—bone cancer	0.000143	0.00357	CcSEcCtD
Alfentanil—Pain—Epirubicin—bone cancer	0.000142	0.00354	CcSEcCtD
Alfentanil—Urticaria—Methotrexate—bone cancer	0.000141	0.00351	CcSEcCtD
Alfentanil—Body temperature increased—Methotrexate—bone cancer	0.00014	0.00349	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—bone cancer	0.000137	0.00341	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—bone cancer	0.000137	0.0034	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000133	0.00331	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—bone cancer	0.000133	0.0033	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—bone cancer	0.000132	0.00329	CcSEcCtD
Alfentanil—Pain—Doxorubicin—bone cancer	0.000132	0.00327	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—bone cancer	0.000131	0.00327	CcSEcCtD
Alfentanil—Hypersensitivity—Methotrexate—bone cancer	0.000131	0.00326	CcSEcCtD
Alfentanil—Asthenia—Methotrexate—bone cancer	0.000127	0.00317	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—bone cancer	0.000127	0.00315	CcSEcCtD
Alfentanil—Pruritus—Methotrexate—bone cancer	0.000126	0.00313	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—bone cancer	0.000122	0.00305	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—bone cancer	0.000122	0.00304	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—bone cancer	0.000122	0.00303	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—bone cancer	0.000119	0.00297	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—bone cancer	0.000118	0.00293	CcSEcCtD
Alfentanil—Dizziness—Methotrexate—bone cancer	0.000117	0.00292	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—bone cancer	0.000113	0.00282	CcSEcCtD
Alfentanil—Vomiting—Methotrexate—bone cancer	0.000113	0.00281	CcSEcCtD
Alfentanil—Rash—Methotrexate—bone cancer	0.000112	0.00279	CcSEcCtD
Alfentanil—Dermatitis—Methotrexate—bone cancer	0.000112	0.00279	CcSEcCtD
Alfentanil—Headache—Methotrexate—bone cancer	0.000111	0.00277	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—bone cancer	0.00011	0.00275	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—bone cancer	0.00011	0.00274	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—bone cancer	0.000109	0.00271	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—bone cancer	0.000106	0.00263	CcSEcCtD
Alfentanil—Nausea—Methotrexate—bone cancer	0.000105	0.00263	CcSEcCtD
Alfentanil—Rash—Epirubicin—bone cancer	0.000105	0.00261	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—bone cancer	0.000105	0.00261	CcSEcCtD
Alfentanil—Headache—Epirubicin—bone cancer	0.000104	0.00259	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—bone cancer	0.000102	0.00253	CcSEcCtD
Alfentanil—Nausea—Epirubicin—bone cancer	9.87e-05	0.00246	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—bone cancer	9.78e-05	0.00243	CcSEcCtD
Alfentanil—Rash—Doxorubicin—bone cancer	9.7e-05	0.00241	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—bone cancer	9.69e-05	0.00241	CcSEcCtD
Alfentanil—Headache—Doxorubicin—bone cancer	9.63e-05	0.0024	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—bone cancer	9.14e-05	0.00227	CcSEcCtD
